SCHEMBL5330338

SCHEMBL5330338

COc1ccc(-c2csc3nc(C45CC6CC(CC(C6)C4)C5)cn23)cc1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
MAPT P10636 4/20 0.42
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
ALDH1A1 P00352 9/20 0.39
MEN1 O00255 3/20 0.39
LMNA P02545 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
NR1I2 O75469 1/20 0.39
PGR P06401 1/20 0.39
RARA P10276 1/20 0.39
HSPD1 P10809 1/20 0.39
RARB P10826 1/20 0.39
RARG P13631 1/20 0.39
GOT1 P17174 1/20 0.39
GLRA1 P23415 1/20 0.39
BLM P54132 1/20 0.39
HSPE1 P61604 1/20 0.39
KDM4E B2RXH2 4/20 0.38
PKM P14618 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5330382 0.99 KMT2A (0.41) KMT2AMAPTIDO1TDO2ALDH1A1
SCHEMBL5332651 0.92 ALDH1A1 (0.38) KMT2AMAPTIDO1TDO2ALDH1A1
SCHEMBL5328122 0.92 IDO1 (0.40) KMT2AMAPTIDO1TDO2ALDH1A1
Hydrochloric Acid SCHEMBL5333141 0.91 ALDH1A1 (0.37) KMT2AMAPTIDO1TDO2ALDH1A1
Hydrochloric Acid SCHEMBL5333618 0.91 IDO1 (0.39) KMT2AMAPTIDO1TDO2ALDH1A1
SCHEMBL5326124 0.91 IDO1 (0.39) KMT2AMAPTIDO1TDO2ALDH1A1
Hydrochloric Acid SCHEMBL5330327 0.90 IDO1 (0.39) KMT2AMAPTIDO1TDO2ALDH1A1
SCHEMBL8226836 0.88 KMT2A (0.36) KMT2AMAPTIDO1TDO2ALDH1A1
SCHEMBL5327371 0.87 SMN1; SMN2 (0.42) KMT2AMAPTIDO1ALDH1A1MEN1
SCHEMBL14340781 0.86 ATP4A (0.39) KMT2AIDO1TDO2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US claimed
WO-2007148113-A1 METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 WO claimed
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US disclosed
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US disclosed
US-20070299113-A1 Metabotropic glutamate receptor modulators MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 US disclosed
WO-2007148113-A1 METABOTROPIC GLUTAMATE RECEPTOR MODULATORS MERZ PHARMA GMBH & CO. KGAA (DE) 2007-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299113-A1 Metabotropic glutamate receptor modulators GRM1, GRM2, GRM3 KMT2A 1294/4885MAPT 794/4885IDO1 3139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.